Comparative efficacy of TAS-102 and chemotherapy rechallenge in the third-line setting and beyond in patients with advanced colorectal cancer: A retrospective study.

Authors: Kanan Alshammari, Rakan Alanazi, Khalid Alotaibi, Murtada Mohamed Ali, Ahmed Abushara, Zainab Albahrani, Afrah Alsehali, Reem Almesfir, Razan Alsubaie, Mohammad Alkaiyat, Husam Shehata, Fouad Sabatin, Mohammed Ahmed Algarni

Published: 2025-01-27

DOI: 10.1200/jco.2025.43.4_suppl.78

Source: Full article

Comparative efficacy of TAS-102 and chemotherapy rechallenge in the third-line setting and beyond in patients with advanced colorectal cancer: A retrospective study.

Abstract